Royal Bank of Canada’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-400
Closed -$29K 6732
2019
Q2
$29K Sell
400
-200
-33% -$14.2K ﹤0.01% 5527
2019
Q1
$41K Buy
600
+300
+100% +$19.4K ﹤0.01% 5267
2018
Q4
$18K Buy
+300
New +$18.8K ﹤0.01% 5630
2018
Q1
Sell
-8,000
Closed -$604K 6376
2017
Q4
$604K Buy
+8,000
New +$584K ﹤0.01% 3656
2016
Q1
Sell
-30,000
Closed -$2M 6380
2015
Q4
$2M Buy
+30,000
New +$2M ﹤0.01% 2551

Other funds holding CL

Royal Bank of Canada's CL Position: Q1 2026 in Review

Royal Bank of Canada increased its Colgate-Palmolive (CL) stake by 4.4% in Q1 2026, buying an estimated $18.6M and bringing the position to 4,940,013 shares worth $421M. The position accounts for 0.07% of the portfolio, ranked #245.

Royal Bank of Canada first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $719M in Q4 2020. 1,953 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Royal Bank of Canada held 4,940,013 shares of Colgate-Palmolive worth $421M as of Q1 2026.
  • Royal Bank of Canada bought 208,806 Colgate-Palmolive shares in Q1 2026, an estimated $18.6M.
  • Colgate-Palmolive made up 0.07% of Royal Bank of Canada's portfolio in Q1 2026, its #245 holding.
  • Royal Bank of Canada first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Colgate-Palmolive position peaked at $719M in Q4 2020.
  • 1,953 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.